Similar to the application of NaV channel-expressing cell lines for the identification of molecules that could be used for pain management, other cell lines, such as the rhabdomyosarcoma cell line, which stably expresses the muscle subtype of nAChR, have successfully been employed for patch-clamp electrophysiology in antivenom research. Here, CHRNA4 is linked to rhabdomyosarcoma.